CHANTIX
What it isPartial agonist at the alpha-4-beta-2 nicotinic receptor; smoking cessation.
Why this oneThe most effective single agent for quitting, because partial agonism both reduces craving and blunts the reward of smoking.
What limits itNausea is common and dose-related. Start one to two weeks before the quit date; renally adjusted.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Smoking cessation | Adults | 0.5 mg QD (days 1–3), then 0.5 mg BID (days 4–7) | 1 mg BID for 12 weeks (may add 12 more weeks) | 1 mg BID |
Titration Titrate over the first week before reaching 1 mg BID.
Renal Severe impairment (CrCl <30 mL/min): start 0.5 mg QD, titrate to 0.5 mg BID. ESRD on hemodialysis: max 0.5 mg QD.
Hepatic Undefined
Pregnancy No suggested increased risk of major birth defects vs. women who smoke; smoking itself carries fetal risk.
Lactation Undefined
NO BOXED WARNINGS
Principal riskNausea; vivid dreams
Cost, est. cash$5–$150/month
Generic entry2021
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

Open Varenicline in the interactive console ↗

